Induced Vascular Normalization-Can One Force Tumors to Surrender to a Better Microenvironment?
Xu Xin Sun1,2,3,4, Zeynab Nosrati1,2,4, Janell Ko1
1Experimental Therapeutics, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Pharmaceutics
|August 26, 2023
Summary
Enhancing cancer immunotherapy involves combining treatments with drug delivery systems. This approach aims to normalize tumor blood vessels and improve immune cell function for better patient survival outcomes.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Immunotherapy has revolutionized cancer treatment, but further improvements in patient survival are needed.
- Enhancing immunotherapy efficacy requires novel combination strategies.
- Tumor angiogenesis and the tumor microenvironment significantly impact immunotherapy response.
Purpose of the Study:
- To explore innovative combination strategies for enhancing cancer immunotherapy.
- To investigate the role of drug delivery systems in improving immunotherapy outcomes.
- To identify future therapeutic approaches for doubling overall survival rates in cancer patients.
Main Methods:
- Review of current immunotherapy research and cancer angiogenesis.
- Analysis of major angiogenesis targets affecting the tumor microenvironment and immune cells.
- Evaluation of drug delivery systems for promoting tumor vascular normalization.
Main Results:
- Combination therapies normalizing tumor vasculature and altering the immune microenvironment show promise.
- Drug delivery systems offer potential for enhancing vascular normalization.
- Targeting angiogenesis can modulate the tumor microenvironment to support immunotherapy.
Conclusions:
- Combining immunotherapy with vascular normalization strategies holds significant potential for future cancer treatment.
- Drug delivery systems are key to achieving therapeutic gains in immunotherapy.
- Optimizing the tumor microenvironment is crucial for maximizing immunotherapy benefits.
Related Concept Videos
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
01:10Mechanism of Angiogenesis
5.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K
01:27Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555